News | October 22, 2014

First Texas Hospital to Implant Solo Smart Aortic Pericardial Heart Valve

Heart Hospital of Austin implants the Solo Smart Heart Valve


Oct. 22, 2014 — Cardiothoracic and Vascular Surgeons became the first in Texas to implant the Solo Smart Aortic Pericardial Heart Valve. Faraz Kerendi, M.D. and Stephen J. Dewan M.D., performed the procedure at Heart Hospital of Austin.

The Solo Smart valve is the first valve with a removable stent to be approved in the U.S. market. Designed from bovine pericardium, the valve is fully biological, with no synthetic material added. This prosthesis mimics the healthy native aortic valve, preserves the aortic root physiology, eliminates excess synthetic material and maximizes blood flow.

The Solo Smart valve also features a removable nickel-titanium alloy stent, which provides support during implantation, but it is completely removed once the valve is sutured in. Once the stent is removed following implantation, the Solo Smart valve becomes an entirely stentless valve, providing low pressure gradients and large openings.

The Solo Smart Aortic Pericardial Heart Valve was approved by the U.S. Food and Drug Administration (FDA) in July 2014. Cardiothoracic and Vascular Surgeons will be training surgeons on how to implant the new valve at Heart Hospital of Austin, which is one of four current training sites across the United States.


Related Content

News | Heart Valve Technology

Sept. 1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspid ...

Home September 04, 2024
Home
News | Heart Valve Technology

June 27, 2024 — The sheer scale of undiagnosed heart valve disease in our aging population has been revealed for the ...

Home June 27, 2024
Home
News | Heart Valve Technology

June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed ...

Home June 21, 2024
Home
News | Heart Valve Technology

June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial ...

Home June 10, 2024
Home
News | Heart Valve Technology

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

Home April 17, 2024
Home
News | Heart Valve Technology

April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...

Home April 01, 2024
Home
News | Heart Valve Technology

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

Home January 04, 2024
Home
News | Heart Valve Technology

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

Home December 22, 2023
Home
News | Heart Valve Technology

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the ...

Home December 18, 2023
Home
News | Heart Valve Technology

December 12, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement ...

Home December 12, 2023
Home
Subscribe Now